Fate Therapeutics, Inc. (NASDAQ:FATE) Reported Earnings Last Week And Analysts...

Published on 15 Nov 2024 on Simply Wall St. · via Yahoo Finance

Fate Therapeutics, Inc. (NASDAQ:FATE) investors will be delighted, with the company turning in some...

Read the rest of the article

Start tracking your investments with Statfolio

Fate Therapeutics, Inc. (NASDAQ:FATE) investors will be delighted, with the company turning in so...

Simply Wall St. · via Yahoo Finance 15 Nov 2024

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript February 26, 2024 Fate The...

Insider Monkey via Yahoo Finance 1 Mar 2024

It's been a good week for Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders, because the company...

Simply Wall St. via Yahoo Finance 29 Feb 2024

Fate Therapeutics FATE reported fourth-quarter 2023 loss of 45 cents per share, narrower than the...

Zacks via Yahoo Finance 27 Feb 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 27 Feb 2024

Insiders who bought US$698.1k worth of Fate Therapeutics, Inc. (NASDAQ:FATE) stock in the last ye...

Simply Wall St. via Yahoo Finance 29 Dec 2023

Fate Therapeutics FATE reported a loss of 46 cents per share in the third quarter of 2023, narrow...

Zacks via Yahoo Finance 9 Nov 2023

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript November 8, 2023 Operator:...

Insider Monkey via Yahoo Finance 9 Nov 2023

Fate Therapeutics FATE reported a loss of 54 cents per share in the second quarter of 2023, narro...

Zacks via Yahoo Finance 9 Aug 2023

Viewing insider transactions for Fate Therapeutics, Inc.'s (NASDAQ:FATE ) over the last year, we ...

Simply Wall St. via Yahoo Finance 22 Jul 2023